NEW YORK — Scleral imbrication combined with pars plana vitrectomy and foveal-sparing internal limiting membrane peel can be an effective surgical option for the treatment of myopic traction maculopathy, leading to a high rate of success.
“Scleral imbrication has been previously described as a technique for macular hole retinal detachment associated with high myopia. In a study, we looked at using it in combination with pars plana vitrectomy (PPV) and foveal-sparing internal limiting membrane (ILM) peel as a surgical method for the treatment of myopic traction maculopathy (MTM),”